Literature DB >> 8553097

Serodiagnosis of melioidosis in Malaysia.

J Vadivelu1, S D Puthucheary, G S Gendeh, N Parasakthi.   

Abstract

Current diagnosis of melioidosis is based on bacterial culture and/or serology which is becoming increasingly useful. An IgM-ELISA using heat-killed whole cells of Pseudomonas pseudomallei was developed and compared with an indirect haemagglutination technique (IHAT) and an indirect immunofluorescent technique(IFAT). The IgM-ELISA using a P:N ratio of > or = 2 had a sensitivity of 91% and a specificity of 96%. All 3 assays were further used in a seroepidemiological survey amongst different groups of patients and healthy individuals. It was found that the IFAT performed better than the IHAT, detecting antibodies to P. pseudomallei in 6% of diabetics, 5% of pyrexics, 8% of pregnant women and 3% of farmers. For the same groups the IgM-ELISA detected antibodies in 1% of pyrexics, 8% of pregnant women and a further 14% of farmers. The IgM-ELISA was found to be sensitive and useful for the serological diagnosis of acute melioidosis.

Entities:  

Mesh:

Year:  1995        PMID: 8553097

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  10 in total

1.  Recombinant truncated flagellin of Burkholderia pseudomallei as a molecular probe for diagnosis of melioidosis.

Authors:  Yao-Shen Chen; David Shiuan; Ssu-Ching Chen; Soi-Moi Chye; Ya-Lei Chen
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

2.  Brief communication genotyping of Burkholderia pseudomallei revealed high genetic variability among isolates from a single population group.

Authors:  Abdelrahman Mohammad Zueter; Zaidah Abdul Rahman; Chan Yean Yean; Azian Harun
Journal:  Int J Mol Epidemiol Genet       Date:  2015-09-09

3.  Imported Case of Melioidosis in Oman: Case Report.

Authors:  Nada Al Tamtami; Faryal Khamis; Amina Al-Jardani
Journal:  Oman Med J       Date:  2017-01

4.  Evaluation of a new commercially available immunoglobulin M and immunoglobulin G immunochromatographic test for diagnosis of melioidosis infection.

Authors:  A J Cuzzubbo; V Chenthamarakshan; J Vadivelu; S D Puthucheary; D Rowland; P L Devine
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

5.  Accuracy of enzyme-linked immunosorbent assay using crude and purified antigens for serodiagnosis of melioidosis.

Authors:  Narisara Chantratita; Vanaporn Wuthiekanun; Aunchalee Thanwisai; Direk Limmathurotsakul; Allen C Cheng; Wirongrong Chierakul; Nicholas P J Day; Sharon J Peacock
Journal:  Clin Vaccine Immunol       Date:  2006-11-08

6.  Comparison of in-house IgM and IgG ELISAs for the serodiagnosis of melioidosis in Malaysia.

Authors:  Shirley Yi Fen Hii; Noor Azila Ali; Norazah Ahmad; Fairuz Amran
Journal:  J Med Microbiol       Date:  2017-10-19       Impact factor: 2.472

7.  Use of Recombinant Escherichia coli Strains in Immunofluorescence Assays for Melioidosis Diagnosis.

Authors:  Kanoknart Lantong; Jirarat Songsri; Sueptrakool Wisessombat; Wanida Mala; Warinda Prommachote; Wilaiwan Senghoi; Manas Kotepui; Jedsada Kaewrakmuk; Treenate Jiranantasak; Apichai Tuanyok; Wiyada Kwanhian Klangbud
Journal:  Pathogens       Date:  2021-05-06

8.  Potential immunogenic polypeptides of Burkholderia pseudomallei identified by shotgun expression library and evaluation of their efficacy for serodiagnosis of melioidosis.

Authors:  Suat Moi Puah; S D Puthucheary; Kek Heng Chua
Journal:  Int J Med Sci       Date:  2013-03-13       Impact factor: 3.738

Review 9.  Burkholderia vaccines: are we moving forward?

Authors:  Leang-Chung Choh; Guang-Han Ong; Kumutha M Vellasamy; Kaveena Kalaiselvam; Wen-Tyng Kang; Anis R Al-Maleki; Vanitha Mariappan; Jamuna Vadivelu
Journal:  Front Cell Infect Microbiol       Date:  2013-02-05       Impact factor: 5.293

10.  Multiple-antigen ELISA for melioidosis--a novel approach to the improved serodiagnosis of melioidosis.

Authors:  Yuka Hara; Chui-Yoke Chin; Rahmah Mohamed; Savithri D Puthucheary; Sheila Nathan
Journal:  BMC Infect Dis       Date:  2013-04-04       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.